Stock screenerAll disclosures →
EDGAR →
SLDB
Conviction 80HealthcareScan · Tue, Sep 8, 2026Hanging man
SLDB$9.95-2.93%
ResistanceSupportVol 14Vol MA14 841.11K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price9.95
Change-2.93%
Gap-2.20%
Rel volume0.57×
Avg volume811.95K
Avg $ vol7.77M
SMA 209.58
SMA 509.32
SMA 2007.34
Price vs 50+6.79%
Price vs 200+35.56%
MA stackbullish
50/200 cross—
Supertrendup · 8.87
RSI (14)56
MACD hist0.05
MACD cross—
Stoch %K / %D68 / 84
ADX (14)17
+DI / −DI29 / 25
RSI divergenceBearish
MACD divergenceBearish
ATR %+5.08%
ADR %4.55%
52w high11.15
52w low3.93
From 52w high-10.76%
Above 52w low+153.18%
New 52w highNo
SqueezeOff
Bollinger width19.85%
%B0.70
Donchian pos73.23%
Donchian high10.48
Donchian low8.50
AVWAP (52w high)9.32
vs AVWAP high+6.70%
AVWAP (52w low)7.37
vs AVWAP low+35.02%
OBV trendUp
Chaikin MF (20)0.32
Today vs 20d0.57×
Avg vol (14d)841.11K
Avg vol (20d)811.95K
Avg $ vol (20d)7.77M
Market cap1.07B
RS 3m (vs SPY)+48.56%
RS 6m (vs SPY)+37.31%
RS line new highNo
Trend template8/8
Technical rank82.9
1 week+3.86%
1 month+18.59%
3 months+55.23%
6 months+24.06%
1 year+80.91%
YTD+82.57%
P/E-9.10
P/B2.85
P/S131.81
P/FCF-6.78
EPS-1.99
Div yield—
ROE-31.34%
ROA-27.87%
Debt/Eq—
Current13.82
EV/EBITDA-5.11
Gross margin—
Net margin—
Rev growth-40.57%
EPS growth-56.72%
Price target19.17
Target upside92.66%
Analyst ratingBuy
Institutional113.81%
Ent. value907.5M
Revenue0
Net income-17.98M
Gross profit—
Free cash flow-157.44M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out98.45M
Employees121
ListedThu, Jan 25, 2018
Free float66.77M
Float %67.9%
Short interest16.62M
Days to cover19.6d
Short volume62.1%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.38 vs −$0.43
Last surprise+11.6% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank82.9 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHanging man
News sentiment—
Financials as of Thu, Sep 30, 2021 · quarterly.
Congress activity
Disclosed STOCK Act trades in SLDB
No recent disclosed trades by Congress in SLDB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in SLDB · 7 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
SMITH IAN F Director · Common Stock · 2026-07-02 | Exercise | 3.44K | — | 2026-07-02 | 2026-07-07 |
SMITH IAN F Director · Restricted Stock Units · 2026-07-02 | Exercise | 3.44K | — | 2026-07-02 | 2026-07-07 |
Tan Kevin CFO & Treasurer · Restricted Stock Units · 2026-01-29 | Grant | 56.65K | $0 | 2026-01-29 | 2026-04-21 |
Howton David T Chief Operating Officer · Restricted Stock Units · 2026-01-29 | Grant | 79.34K | $0 | 2026-01-29 | 2026-04-21 |
Brooks Gabriel Chief Medical Officer · Restricted Stock Units · 2026-01-29 | Grant | 58.85K | $0 | 2026-01-29 | 2026-04-21 |
Hanrahan Jessie Chief Regulatory Officer · Restricted Stock Units · 2026-01-29 | Grant | 54.92K | $0 | 2026-01-29 | 2026-04-21 |
Cumbo Alexander President and CEO · Restricted Stock Units · 2026-01-29 | Grant | 169.4K | $0 | 2026-01-29 | 2026-04-21 |
Herzich Paul Chief Technology Officer · Restricted Stock Units · 2026-01-29 | Grant | 54.92K | $0 | 2026-01-29 | 2026-04-21 |
SEC filings
EDGAR filings in SLDB · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.